Citalopram Discontinuation in Young Patients
Introduction to Citalopram Discontinuation
- The American Academy of Child and Adolescent Psychiatry recommends a gradual dose reduction of citalopram over several weeks to avoid withdrawal syndrome, which can be characterized by dizziness, fatigue, lethargy, and other symptoms 1
Protocol for Discontinuation
- The American Academy of Child and Adolescent Psychiatry suggests avoiding discontinuation during periods of stress or significant life changes for the patient 2
- It is recommended to inform the patient of potential withdrawal symptoms so they can recognize them 3
Special Considerations
- Young patients may be more sensitive to the effects of discontinuation and require an even more gradual dose reduction 2
- The American Academy of Child and Adolescent Psychiatry recommends monitoring for signs of suicidal ideation, particularly during the discontinuation period 3
Monitoring and Emergency Consultation
- The American Academy of Child and Adolescent Psychiatry advises monitoring for the appearance of withdrawal symptoms, especially within 24 to 48 hours following each dose reduction 1
- If severe symptoms such as suicidal ideation, extreme agitation, or severe physical symptoms appear, it is recommended to consult an emergency doctor 2
- In case of serotonin syndrome (confusion, agitation, tremors, hyperreflexia, muscle rigidity, hypertension, tachycardia), the American Academy of Child and Adolescent Psychiatry recommends seeking immediate medical attention 1